vimarsana.com

Latest Breaking News On - American heart association circulation - Page 1 : vimarsana.com

Emergency cardiovascular care impact goal outlines three target needs

Emergency cardiovascular care impact goal outlines three target needs
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Heart Attacks Spike Over Christmas and New Year, and It s Not Just the Cold Weather

Heart Attacks Spike Over Christmas and New Year, and It s Not Just the Cold Weather
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

Mealtime matters | Borneo Bulletin Online

ANN/THE STAR – Within the realm of nutrition, an enduring discussion persists: What meal frequency best contributes to optimal health maintenance? Is it preferable to snack on multiple small meals across the day or adhere to fewer, larger meals at conventional mealtimes? The answer isn’t straightforward, as it hinges on an array of factors, including […]

Patients With HFrEF, HFpEF See Different Functional Capacity Benefits With Dapagliflozin

The DETERMINE-Reduced and DETERMINE-Preserved trials demonstrated varying benefits of dapagliflozin on Kansas City Cardiomyopathy Questionnaire Total Symptom Score and Physical Limitation Scale as well as 6-minute walk distance.

From the Clinic to Pharmaceutical Clinical Trials: Considerations for using Coronary CT Angiography (CCTA) in Atherosclerotic Cardiovascular Disease (ASCVD) Clinical Trials

As coronary computed tomography angiography (CCTA) progresses towards becoming the primary imaging modality for not only diagnostic purposes, but also for clinical trial endpoints, there is a need to address the requirements for generating high-quality CCTA image data to ensure accurate and robust CAD assessments. This guest column identifies considerations for the use of CCTA in clinical trials involving Atherosclerotic Cardiovascular Disease (ASCVD).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.